logo

CMPS

COMPASS Pathways
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 2
Sell signal 0
consensus rating "Strong Buy"
EPS Beats Expectation

Key Stats

--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--

About CMPS

Compass Pathways Plc

A UK developer of psilocybin therapy for the treatment of resistant depression

Pharmaceutical
Invalid Date
09/18/2020
NASDAQ Stock Exchange
166
12-31
Depository Receipts (Ordinary Shares)
33 Broadwick Street, London W1F 0DQ, United Kingdom
--
COMPASS Pathways plc is incorporated in England and Wales. COMPASS Pathways plc is a mental health care company that promotes patient access to evidence-based mental health care innovations. The company is motivated by the need to find better ways to help and empower people with mental health challenges who are not helped by existing therapies, and is pioneering a new psilocybin treatment model that combines psilocybin with psychological support.

Company Financials

EPS

CMPS has released its 2024 Q4 earnings. EPS was reported at -0.63, versus the expected -0.64, beating expectations. The chart below visualizes how CMPS has performed over recent quarters, highlighting trends in earnings surprises.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime